The Beauty Health Company (FRA:V7A0)
Germany · Delayed Price · Currency is EUR 1.250
+0.040 (3.31%)
At close: Nov 28, 2025
The Beauty Health Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| 301.92 | 334.29 | 397.99 | 365.88 | 260.09 | 119.09 | Upgrade | |
Revenue Growth (YoY) | -13.15% | -16.00% | 8.78% | 40.67% | 118.39% | -28.53% | Upgrade |
Cost of Revenue | 106.25 | 152 | 242.88 | 117.1 | 81.55 | 51.89 | Upgrade |
Gross Profit | 195.67 | 182.3 | 155.11 | 248.78 | 178.54 | 67.2 | Upgrade |
Selling, General & Admin | 218.63 | 243.77 | 275.93 | 266.18 | 210.27 | 80.97 | Upgrade |
Research & Development | 5.17 | 6.3 | 10.1 | 8.44 | 8.2 | 3.41 | Upgrade |
Operating Expenses | 223.79 | 250.07 | 286.03 | 274.62 | 218.47 | 84.38 | Upgrade |
Operating Income | -28.12 | -67.77 | -130.92 | -25.84 | -39.93 | -17.18 | Upgrade |
Interest Expense | -15.42 | -10.41 | -13.65 | -13.39 | -11.78 | -21.28 | Upgrade |
Interest & Investment Income | 9.66 | 16.64 | 23.17 | 9.18 | 0.04 | - | Upgrade |
Currency Exchange Gain (Loss) | 1.72 | -4.64 | 2.39 | -1.3 | -0.07 | 0.02 | Upgrade |
Other Non Operating Income (Expenses) | 1.24 | 3.23 | 12.22 | 76.69 | -277.5 | -0.05 | Upgrade |
EBT Excluding Unusual Items | -30.93 | -62.95 | -106.79 | 45.34 | -329.24 | -38.48 | Upgrade |
Other Unusual Items | 18.08 | 33.4 | 4.9 | - | -51.4 | - | Upgrade |
Pretax Income | -12.85 | -29.55 | -101.89 | 45.34 | -380.64 | -38.48 | Upgrade |
Income Tax Expense | -1.1 | -0.45 | -1.77 | 1.12 | -1.88 | -9.31 | Upgrade |
Earnings From Continuing Operations | - | -29.1 | -100.12 | 44.22 | -378.76 | -29.18 | Upgrade |
Net Income | -11.75 | -29.1 | -100.12 | 44.22 | -378.76 | -29.18 | Upgrade |
Net Income to Common | -11.75 | -29.1 | -100.12 | 44.22 | -378.76 | -29.18 | Upgrade |
Shares Outstanding (Basic) | 126 | 124 | 132 | 148 | 102 | 34 | Upgrade |
Shares Outstanding (Diluted) | 126 | 142 | 132 | 149 | 102 | 34 | Upgrade |
Shares Change (YoY) | 0.58% | 8.21% | -11.33% | 45.43% | 197.77% | 6.71% | Upgrade |
EPS (Basic) | -0.09 | -0.23 | -0.76 | 0.30 | -3.71 | -0.85 | Upgrade |
EPS (Diluted) | -0.18 | -0.36 | -0.76 | -0.23 | -3.71 | -0.85 | Upgrade |
Free Cash Flow | 38.52 | 15.38 | -0.53 | -118.92 | -39.56 | -15.94 | Upgrade |
Free Cash Flow Per Share | 0.31 | 0.11 | -0.00 | -0.80 | -0.39 | -0.47 | Upgrade |
Gross Margin | 64.81% | 54.53% | 38.97% | 68.00% | 68.65% | 56.43% | Upgrade |
Operating Margin | -9.31% | -20.27% | -32.89% | -7.06% | -15.35% | -14.43% | Upgrade |
Profit Margin | -3.89% | -8.70% | -25.16% | 12.09% | -145.63% | -24.50% | Upgrade |
Free Cash Flow Margin | 12.76% | 4.60% | -0.13% | -32.50% | -15.21% | -13.38% | Upgrade |
EBITDA | -1.57 | -34.09 | -96.24 | -2.97 | -22 | -2.69 | Upgrade |
EBITDA Margin | -0.52% | -10.20% | -24.18% | -0.81% | -8.46% | -2.25% | Upgrade |
D&A For EBITDA | 26.56 | 33.68 | 34.68 | 22.87 | 17.93 | 14.5 | Upgrade |
EBIT | -28.12 | -67.77 | -130.92 | -25.84 | -39.93 | -17.18 | Upgrade |
EBIT Margin | -9.31% | -20.27% | -32.89% | -7.06% | -15.35% | -14.43% | Upgrade |
Effective Tax Rate | - | - | - | 2.46% | - | - | Upgrade |
Advertising Expenses | - | 1.7 | 2.3 | 3.8 | 3.2 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.